Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening [...]
Gilead Shot Provides Total Protection From HIV in Trial of Young African Women
An injection given just twice a year could herald a [...]
Los fármacos de acción prolongada podrían revolucionar el tratamiento de VIH
Nuevos tratamientos en desarrollo, que incluyen píldoras de una vez [...]
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment
New regimens in development, including once-weekly pills and semiannual shots, [...]
10 Charged in $20 Million Scheme to Sell Black-Market H.I.V. Drugs
Federal prosecutors said the defendants encouraged low-income patients to sell [...]
PEPFAR Turned the Tide of AIDS and It’s Now at Risk
In 2003, President Bush started PEPFAR to fight AIDS. But [...]
Why One Drug Company Held Back a Better Drug
Drug companies say patents spur innovation. Can they also do [...]
Expert Panel Recommends New Drugs for HIV Prevention
The “grade A” endorsement means that two additional drugs should [...]
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it [...]
When Politics Saves Lives: a Good-News Story
The decision to fund medications to treat H.I.V.-AIDS patients in [...]